JPS5934891A - Preparation of azaserine by fermentation - Google Patents

Preparation of azaserine by fermentation

Info

Publication number
JPS5934891A
JPS5934891A JP14439982A JP14439982A JPS5934891A JP S5934891 A JPS5934891 A JP S5934891A JP 14439982 A JP14439982 A JP 14439982A JP 14439982 A JP14439982 A JP 14439982A JP S5934891 A JPS5934891 A JP S5934891A
Authority
JP
Japan
Prior art keywords
azaserine
culture
microtetraspora
genus
fermentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP14439982A
Other languages
Japanese (ja)
Inventor
Fusao Tomita
房男 冨田
Isao Kawamoto
勲 川本
Shoji Oda
小田 祥二
Tatsuya Tamaoki
玉沖 達也
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Priority to JP14439982A priority Critical patent/JPS5934891A/en
Publication of JPS5934891A publication Critical patent/JPS5934891A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To prepare azaserine useful as an antibacterial agent and antitumor agent, by culturing a microbial strain belonging to Microtetraspora genus. CONSTITUTION:Microorganism belonging to Microtetraspora genus and capable of producing azaserine, e.g. Microtetraspora glauca ATCC23057, is inoculated in a nutrient medium, and cultured at 25-40 deg.C, preferably 28-38 deg.C, at 4-10pH, preferably 6-8pH, for about 1-7 days in a liquid medium, and the objective azaserine is separated from the culture liquid.

Description

【発明の詳細な説明】 本発明はアザセリンの製造法に関する。さらに詳しくは
、ミクロテトラスポラ属に属し、アザセリン生産能を有
する微生物を栄養培地に培養し、培養物中にアザセリン
を蓄積せしめ、培養物から蓄積したアザセリンを採取す
ることを%徴とする発酵法によるアザセリンの製造法に
関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing azaserine. More specifically, a fermentation method is characterized in that a microorganism belonging to the genus Microtetraspora and capable of producing azaserine is cultured in a nutrient medium, azaserine is accumulated in the culture, and the accumulated azaserine is collected from the culture. relates to a method for producing azaserine.

、アザセリンは、抗菌活性、抗腫瘍活性を有する物質と
して知られている。従来アザセリンの製法としてはスト
レプトマイセス・フラジリスに属する菌株をオリ用する
方法が知られており、アザセリンの物理化学的性質とと
もに報告されている( Index of Antib
iotics fromActinomyoetes、
 167頁、1967年、Handbookof An
tibiotio Compounds vow IV
 part 145頁、1980年)。
, azaserine is known as a substance having antibacterial and antitumor activities. Conventionally, azaserine has been produced using a strain belonging to Streptomyces fragilis, which has been reported along with the physicochemical properties of azaserine (Index of Antib
iotics from Actinomyotes,
167 pages, 1967, Handbook of An
Tibiotio Compounds Vow IV
part 145, 1980).

本発明者はミクロテトラスポラ属の微生物の産生ずる抗
菌物質について検討の結果、ミクロテトラスポラ・グラ
ウカ(Microtetrasporag’1auca
 )の菌がアザセリンを生産することを見出し本発明を
完成した。
As a result of research on antibacterial substances produced by microorganisms of the genus Microtetraspora, the present inventor found that Microtetraspora glauca (Microtetraspora g'1auca)
) was found to produce azaserine, and the present invention was completed.

以下、本発明について詳細に説明する。The present invention will be explained in detail below.

使用する微生物としては、ミクロテトラスポラ属に属し
、アザセリン生産能を有するものであればいかなるもの
も使用できる。
Any microorganism can be used as long as it belongs to the genus Microtetraspora and has the ability to produce azaserine.

好適な菌の例は、ミクロテトラスポラ、グラウカATC
C23057があげられる。
Examples of suitable bacteria include Microtetraspora, Glauca ATC
C23057 is mentioned.

培養は通常の放線菌の培養法が一般に用いられる。栄養
源としては炭素源、窒素源、熱機物等を含有したものが
用いられる。
For culturing, a normal method for culturing actinomycetes is generally used. As the nutrient source, one containing a carbon source, a nitrogen source, a heat source, etc. is used.

戻素源としてはブドウ糖、殿粉、デキストリン、マンノ
ース、フラクトース、シュークロース、糖蜜などが単独
または組み合わせて用いられる。さらに、菌の資化能に
よっては炭化水素、アルコール類、グリセリン、有機酸
なども用いうる。無機および有機の窒素源としては塩化
アンモン、硫酸アンモン、硝酸アンモン、硝酸ソーダ、
尿素など、あるいは天然窒素含有物、例えばペプトン、
肉エキス、酵母エキス、乾燥酵母、コーン・スチープ・
9カー、大豆粉、カザミノ酸などが単独または組み合わ
せて用いられる。その#丘か、必要に応じて食塩、塩化
カリ、炭酸カルシウム、燐酸第一カリ、燐酸第二カリ等
燐酸塩、アルカリ金属塩などの無機塩類を加えるはか、
使用菌の生育やアザセリンの生産を促進する有機物や無
機物を適当に添加することができる。
As the return element source, glucose, starch, dextrin, mannose, fructose, sucrose, molasses, etc. are used alone or in combination. Furthermore, depending on the assimilation ability of the bacteria, hydrocarbons, alcohols, glycerin, organic acids, etc. may also be used. Inorganic and organic nitrogen sources include ammonium chloride, ammonium sulfate, ammonium nitrate, sodium nitrate,
such as urea, or natural nitrogen-containing substances such as peptone,
Meat extract, yeast extract, dry yeast, corn steep
Soybean powder, soybean flour, casamino acids, etc. may be used alone or in combination. If necessary, add inorganic salts such as common salt, potassium chloride, calcium carbonate, phosphates such as potassium chloride, dipotassium phosphate, and alkali metal salts.
Organic or inorganic substances that promote the growth of the bacteria used and the production of azaserine can be appropriately added.

培養法としては、液体培養法、とくに深部攪拌培養法が
もっとも適している。培養は温度は25〜40℃、特に
28〜38℃で、培地のpHはアンモニア水や炭酸アン
モニア水などを添加して、pH4〜io、好ましくは6
〜8で行われる。液体培養で通常1日ないし7日培養を
行なうと、目的物質が培養液中に生成蓄積される。培養
液中の生成量が最大に達したときに培養を停止し、菌体
をf別しで得られる培養液中よシ目的物を精製単離する
The most suitable culture method is a liquid culture method, especially a deep agitation culture method. The culture temperature is 25 to 40°C, especially 28 to 38°C, and the pH of the culture medium is adjusted to pH 4 to io, preferably 6 by adding aqueous ammonia or aqueous ammonia carbonate.
It will be held at ~8. When culture is carried out in liquid culture for usually 1 to 7 days, the target substance is produced and accumulated in the culture solution. When the production amount in the culture solution reaches the maximum, the culture is stopped, the bacterial cells are separated, and the target product is purified and isolated from the obtained culture solution.

培養f液からのアザセリンの単MM14には、微生物代
謝生産物を、その培養液から単離するためにふつう用い
られる分離、精製の方法が利用される。
The single MM 14 of azaserine from culture fluid utilizes separation and purification methods commonly used to isolate microbial metabolic products from their culture fluids.

以下本発明の態様を実施例によって説明する。Aspects of the present invention will be explained below using examples.

実施例1゜ 種菌としてミクロテトラスポラ・グラウカATCC23
057を用いる。該菌株を2を容量の三角フラスコ中の
種培地〔デキストリン20り/1.グルコース101/
l、ペプトン10 f/l、 :17−y ・スチープ
・リカー5f/l、酵母エキス1 f / l、 KH
2PO40,5f / t。
Example 1 Microtetraspora glauca ATCC23 as inoculum
057 is used. The strain was grown in a seed medium [20 liters of dextrin/1. Glucose 101/
l, peptone 10 f/l, :17-y ・Steep liquor 5 f/l, yeast extract 1 f/l, KH
2PO40,5f/t.

MySOa ・7Hz OO,5W/lの組成を有する
培地pH7,2(殺菌前))300rJに種菌し、28
℃で24時間振とう(220r、p、m、 )培養する
MySOa ・7Hz OO, medium pH 7.2 (before sterilization)) 300rJ with the composition of 28
Culture with shaking (220r, p, m, ) for 24 hours at ℃.

得られた種培養を30を容量のジャーファーメンタ−中
の下記組成の発酵培地15tに、5%(容量)の割合で
植菌し、30℃で通気攪拌方式(回転数250 r、p
、m、;通気量15 t/min )によシ培養を行う
The obtained seed culture was inoculated at a rate of 5% (volume) into 15 tons of fermentation medium having the following composition in a jar fermenter with a capacity of 30℃, and was incubated at 30°C with aeration stirring (rotation speed 250 r, p
, m,; aeration rate 15 t/min).

発酵培地組成:グリセリン20 W/l、グルコース1
0f/1.、綿実粕20 f’/l、 :I −7・ス
チープ・リカー5 f/l、’乾燥酵母10f/ t、
 K2HPO40,5f/ 1. My 804・7H
z OO,5f/l、pH7,2(殺菌前)にNaOH
で調整する。
Fermentation medium composition: glycerin 20 W/l, glucose 1
0f/1. , cottonseed meal 20 f/l, :I-7・steep liquor 5 f/l, 'dry yeast 10 f/t,
K2HPO40,5f/1. My 804・7H
z OO, 5f/l, pH 7.2 (before sterilization) with NaOH
Adjust with.

培地のpHはアンモニア水を用いてp H6,5〜7.
5に調節する。72時間培養した結果培養液中にアザセ
リンを標品とし、これに換算した値で30μr / r
PLeの濃度で抗菌物質が蓄積していた。
The pH of the medium was adjusted to pH 6.5-7. using ammonia water.
Adjust to 5. As a result of culturing for 72 hours, azaserine was used as a standard in the culture solution, and the value converted to this was 30μr/r.
Antibacterial substances were accumulated at the concentration of PLe.

培養液より菌体及び沈殿物をr別し、沢液13tを得た
。これを活性炭(2t)を充填し九カラムに吸着させ、
水洗拶50%メタノールで活性画分を溶出し、メタノー
ルを留去したあと凍結乾燥して粉末とした。これを水飽
和ブタノールに溶解し、同じ溶媒で充填したシリカゲル
カラム(500耐)で同じ溶媒で展開した。
Bacterial cells and precipitates were separated from the culture solution to obtain 13 tons of sap. This was packed with activated carbon (2t) and adsorbed into nine columns.
The active fraction was washed with water and eluted with 50% methanol, and after distilling off the methanol, it was freeze-dried to form a powder. This was dissolved in water-saturated butanol and developed with the same solvent in a silica gel column (500 resistance) packed with the same solvent.

活性画分を集め溶媒を留去後少景の50夕(メタノール
に溶解し、同じ溶媒で充填したセファデックスLH−2
0を用いて同じ溶媒で展開して活性画分を集める。これ
らを濃縮乾固することによジアザセリンの粉末8岬が回
収される。
The active fractions were collected and the solvent was distilled off, and then the solvent was distilled off.
0 and collect the active fraction by developing with the same solvent. By concentrating and drying these, 8 capes of diazaserine powder are recovered.

得られたアザセリンの物理化学的性質は次の通りであり
、標品のものと一致する。
The physicochemical properties of the obtained azaserine are as follows, and are consistent with those of the standard product.

元素分析値 C:34.80%、N : 24.409
g(実測値)H: 4.20 ’X UV吸収極太 250.5 mμ(pH7,0緩衝液中
で)分子量 173 分子式 C6N7 N304 特許出願A(102)協和醗酵工業株式会社代表者 木
下祝部
Elemental analysis value C: 34.80%, N: 24.409
g (actual value) H: 4.20'

Claims (1)

【特許請求の範囲】[Claims] ミクロテトラスポラ属に属し、アザセリン生産能を有す
る微生物を栄養培地に培養し、培養物中にアザセリンを
蓄積せしめ一1培養物から蓄積したアザセリンを採取す
ることを特徴とする発酵法によるアザセリンの製造法。
Production of azaserine by a fermentation method characterized by culturing a microorganism belonging to the genus Microtetraspora and having azaserine-producing ability in a nutrient medium, accumulating azaserine in the culture, and collecting the accumulated azaserine from the culture. Law.
JP14439982A 1982-08-20 1982-08-20 Preparation of azaserine by fermentation Pending JPS5934891A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14439982A JPS5934891A (en) 1982-08-20 1982-08-20 Preparation of azaserine by fermentation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14439982A JPS5934891A (en) 1982-08-20 1982-08-20 Preparation of azaserine by fermentation

Publications (1)

Publication Number Publication Date
JPS5934891A true JPS5934891A (en) 1984-02-25

Family

ID=15361254

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14439982A Pending JPS5934891A (en) 1982-08-20 1982-08-20 Preparation of azaserine by fermentation

Country Status (1)

Country Link
JP (1) JPS5934891A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0123170A2 (en) * 1983-04-25 1984-10-31 American Cyanamid Company Antibiotic LL-D05139beta

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0123170A2 (en) * 1983-04-25 1984-10-31 American Cyanamid Company Antibiotic LL-D05139beta
EP0123170A3 (en) * 1983-04-25 1985-08-28 American Cyanamid Company Antibiotic ll-d05139beta

Similar Documents

Publication Publication Date Title
CN101870739B (en) Paenibacillus polymyxa extracellular polysaccharide and application thereof
US5169767A (en) Method of producing trehalose
US3018225A (en) Production of vitamin b12
CN1153823A (en) Fermentative production of vitamin B6
JPS5934891A (en) Preparation of azaserine by fermentation
JPS6010718B2 (en) Process for producing maytansinol, maytanacin and maytansinol propionate
JPS6010720B2 (en) Production method of antibiotic C-15003 P-4
JP3067183B2 (en) Method for producing FR900506 substance
JP2936663B2 (en) Method for producing FR901228 substance
US2985564A (en) Production of puromycin
JPS5920359B2 (en) Production method of polylysine
JPH0639480B2 (en) New macrolide antibiotic M119
JPS6015318B2 (en) New antibiotic SF-1942 substance, its manufacturing method and anticancer agent containing it
JPH04267886A (en) Production of beta-glucooligosaccharide
JPS5953838B2 (en) Method for producing β-hydroxyvaleric acid
US2965547A (en) Process for the production of l-6-diazo-5-oxonorleucine
JPS6040838B2 (en) Method for producing bicyclomycin
JPS6122956B2 (en)
CN116790694A (en) Sword-attached extracellular polysaccharide and application thereof
JPS62195295A (en) Production of cryptosporin by fermentation method
JPS5932120B2 (en) Method for producing 9-β-D arabinofuranosyl adenine
GB1591047A (en) Microbiological production of ubiquinones
JPH03197475A (en) New benzanthracene compound and its production
JPH07206886A (en) Farnesyltransferase inhibitor fo-3929 and its production
JPH0737478B2 (en) Novel bioactive substance KSA-9342 or salt thereof, and method for producing the same